Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No study details or user-facing content appear to be affected.SummaryDifference0.0%

- Check14 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedA new site revision 'Revision: v3.4.2' has been added and the previous 'Revision: v3.4.1' notice removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page now includes a prominent Notice about a lapse in government funding and NIH operating status, and the revision version shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedNew UI elements and labels have been added: a 'Show glossary' option, and updated labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The page footer now shows 'Revision: v3.4.0', replacing the previous 'v3.3.4'.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; there are no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.